Home/Filings/4/0001095449-21-000025
4//SEC Filing

Tamarack Capital Management, LLC 4

Accession 0001095449-21-000025

CIK 0001008586other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 6:57 PM ET

Size

14.5 KB

Accession

0001095449-21-000025

Insider Transaction Report

Form 4
Period: 2021-03-02
Transactions
  • Award

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,223,334 total
  • Purchase

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,930,882 total(indirect: See footnote 2)
Transactions
  • Award

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,223,334 total
  • Purchase

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,930,882 total(indirect: See footnote 2)
Transactions
  • Award

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,223,334 total
  • Purchase

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,930,882 total(indirect: See footnote 2)
Transactions
  • Award

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,223,334 total
  • Purchase

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,930,882 total(indirect: See footnote 2)
Transactions
  • Award

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,223,334 total
  • Purchase

    Common Stock, $0.01 par value

    2021-03-02$1.60/sh+625,000$1,000,0004,930,882 total(indirect: See footnote 2)
Footnotes (3)
  • [F1]The acquired securities are reported on 2 lines because the acquisition results in different ownership positions for the reporting parties.
  • [F2]The reported securities represent 4,223,334 shares held directly by Tamarack Global Healthcare Fund, L.P. ("Fund 1") and 707,548 shares held directly by Tamarack Global Healthcare Fund QP, L.P. ("Fund 2"). Tamarack Capital Management, LLC is the general partner of Fund 1 and Fund 2 and Tamarack Advisers, LP is the investment adviser to Fund 1 and Fund 2. Tamarack Capital GP, LLC is the sole partner of Tamarack Advisers, LP. Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Tamarack Capital GP, LLC may be deemed indirect beneficial owners of the shares held by Fund 1 and Fund 2 for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act").
  • [F3]Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Tamarack Capital GP, LLC disclaim beneficial ownership of any of the shares held by Fund 1 and Fund 2 for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii) under the Act. To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund 1 and Fund 2 for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, if any.

Issuer

STREAMLINE HEALTH SOLUTIONS INC.

CIK 0001008586

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001537996

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:57 PM ET
Size
14.5 KB